CJC-1295 Injectable, 6mg/15mg, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
Published July 2, 2025 · Recall initiated: May 21, 2025
Summary
FDA records drug Class II recall D-0475-2025, published July 2, 2025 and initiated May 21, 2025. Recalling firm: Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado); Status: Ongoing; Reported quantity: 60 syringes; Lot: Lot#: H261968, Exp 12/23/2025; H261358, Exp 5/13/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
- Distributor
- USA Nationwide
- Lot
- Lot#: H261968, Exp 12/23/2025; H261358, Exp 5/13/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, SuiteJuly 2, 2025
- FDATirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness,July 2, 2025
- FDAMethylcobalamin Injectable, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, SuiteJuly 2, 2025
- FDASemaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204,July 2, 2025
- FDALL Bioboost Injectable, Each 1mL contains Methionine 25 mg, Inositol 50 mg, Choline Chloride 50 mg, andJuly 2, 2025
- FDAMetoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska,July 2, 2025
Questions about this recall
Was CJC-1295 Injectable, 6mg/15mg, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 recalled?
Yes. FDA published recall D-0475-2025 on July 2, 2025. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail